Metraipolis › archive › dc_d17aa873df4f

Lung Function and Safety Outcomes in Patients With Moderate-to-Severe COPD Treated With Ensifentrine: A Pooled Analysis of the ENHANCE Trials — Europe PMC PMID:42548501

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42548501
DOI
10.1016/j.chpulm.2025.100210
License (as archived)
solo-consultazione
Archived
2026-11-10T04:06:50.271Z
SHA-256 of the archived text
61a672ce7b277d14bd1e2684cd21ba5e54a7d81391928279c86218f28a55981a
Stable URL of this page
https://metraipolis.com/documento/dc_d17aa873df4f

How to cite

Lung Function and Safety Outcomes in Patients With Moderate-to-Severe COPD Treated With Ensifentrine: A Pooled Analysis of the ENHANCE Trials — Europe PMC PMID:42548501 — Europe PMC (en), https://europepmc.org/article/MED/42548501 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d17aa873df4f (Metraipolis archive dc_d17aa873df4f, sha256 61a672ce7b277d14bd1e2684cd21ba5e54a7d81391928279c86218f28a55981a)
BibTeX
@misc{dcd17aa873df4f,
  title = {Lung Function and Safety Outcomes in Patients With Moderate-to-Severe COPD Treated With Ensifentrine: A Pooled Analysis of the ENHANCE Trials — Europe PMC PMID:42548501},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42548501},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d17aa873df4f; sha256 61a672ce7b277d14bd1e2684cd21ba5e54a7d81391928279c86218f28a55981a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42548501. Agents can read the archived copy with the MCP tool read_document.